Palvella Therapeutics (PVLA) Return on Capital Employed Growth (1y) (2015 - 2026)
Palvella Therapeutics (PVLA) Return on Capital Employed Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - | -3,457.00 |
| 10 | Palvella Therapeutics | 1.88 Bn | 1.62 Bn | - | -289.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -289.00 |
| Dec 31, 2025 | -4,108.00 |
| Sep 30, 2025 | -7,248.00 |
| Jun 30, 2025 | -2,488.00 |
| Mar 31, 2025 | -4,413.00 |
| Dec 31, 2024 | 487.00 |
| Sep 30, 2024 | 10,220.00 |
| Jun 30, 2024 | 5,873.00 |
| Mar 31, 2024 | 12,915.00 |
| Dec 31, 2023 | 3,341.00 |
| Sep 30, 2023 | -2,380.00 |
| Jun 30, 2023 | -1,826.00 |
| Mar 31, 2023 | -6,079.00 |
| Dec 31, 2022 | -2,372.00 |
| Sep 30, 2022 | -1,023.00 |
| Jun 30, 2022 | -360.00 |
| Mar 31, 2022 | -740.00 |
| Dec 31, 2021 | -940.00 |
| Sep 30, 2021 | -2,491.00 |
| Jun 30, 2021 | -3,919.00 |